How does additional diagnostic testing influence the initial diagnosis in patients with cognitive complaints in a memory clinic setting?
Authors:
Open Access
- 20 May 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 44 (1) , 72-77
Abstract
Background: patients suspected of dementia frequently undergo additional diagnostic testing (e.g. brain imaging or neuropsychological assessment) after standard clinical assessment at a memory clinic. This study investigates the use of additional testing in an academic outpatient memory clinic and how it influences the initial diagnosis. Methods: the initial diagnosis after standard clinical assessment (history, laboratory tests, cognitive screening and physical and neurological examination) and the final diagnosis after additional testing of 752 memory clinic patients were collected. We specifically registered if, and what type of, additional testing was requested. Results: additional testing was performed in 518 patients (69%), 67% of whom underwent magnetic resonance imaging, 45% had neuropsychological assessment, 14% had cerebrospinal fluid analysis and 49% had (combinations of) other tests. This led to a modification of the initial diagnosis in 17% of the patients. The frequency of change was highest in patients with an initial non-Alzheimer's disease (AD) dementia diagnosis (54%, compared with 11 and 14% in patients with AD and ‘no dementia’; P < 0.01). Finally, after additional testing 44% was diagnosed with AD, 9% with non-AD dementia and 47% with ‘no dementia’. Conclusion: additional testing should especially be considered in non-AD patients. In the large group of patients with an initial AD or ‘no dementia’ diagnosis, additional tests have little diagnostic impact and may perhaps be used with more restraint.Keywords
This publication has 21 references indexed in Scilit:
- Value of Neuropsychological Tests, Neuroimaging, and Biomarkers for Diagnosing Alzheimer's Disease in Younger and Older Age CohortsJournal of the American Geriatrics Society, 2011
- Added diagnostic value of CSF biomarkers in differential dementia diagnosisNeurobiology of Aging, 2010
- The Added Value of Neuropsychologic Tests and Structural Imaging for the Etiologic Diagnosis of Dementia in Italian Expert CentersAlzheimer Disease & Associated Disorders, 2008
- Role of imaging techniques in the diagnosis of dementiaBritish Journal of Radiology, 2007
- A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2005
- The clinical utility of structural neuroimaging with MRI for diagnosis and differential diagnosis of dementia: a memory clinic studyInternational Journal of Geriatric Psychiatry, 2005
- Advances in the detection of Alzheimer's disease—use of cerebrospinal fluid biomarkersClinica Chimica Acta, 2003
- Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical PracticeArchives of Neurology, 2001
- Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSFNeurology, 1999
- Vascular dementiaNeurology, 1993